BIOHARVEST SCIENCES INC.
BHST · XNASCIK 1723464fmd_1QCHCN69W20X9W8EMTS7GEP0Q3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Dec 31, 2025, 3 periods
Latest annual · FY2025
Millions- Total revenues
- 35
- Gross profit
- 20
- Operating income
- (6)
- Net income
- (11)
- Free cash flow
- (10)
Daily close · BHSTIEX trades only
Apr 03, 2025 to Nov 06, 2026 · 233 sessions1.59 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
BIOHARVEST SCIENCES INC. (BHST) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $34.5 million | $25.2 million | +37% | 40-F 2026-03-31 · proof |
| Gross profit | $20.5 million | $13.9 million | +46.9% | 40-F 2026-03-31 · proof |
| Operating income | -$5.6 million | -$7 million | 40-F 2026-03-31 · proof | |
| Net income | -$11.1 million | -$12.9 million | 40-F 2026-03-31 · proof | |
| Cash from operating activities | -$7.2 million | -$6.7 million | 40-F 2026-03-31 · proof | |
| Free cash flow | -$9.6 million | -$9.5 million | 40-F 2026-03-31 · proof | |
| Total assets | $47.7 million | $25 million | +90.7% | 40-F 2026-03-31 · proof |
| Total liabilities | $22.2 million | $23.7 million | -6.1% | 40-F 2026-03-31 · proof |
| Cash and cash equivalents | $23 million | $2.4 million | +863.4% | 40-F 2026-03-31 · proof |
- What was BIOHARVEST SCIENCES INC. (BHST)'s revenue in fiscal 2025?
- BIOHARVEST SCIENCES INC. (BHST) reported revenue of $34.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $25.2 million the year before (+37%). Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What was BIOHARVEST SCIENCES INC. (BHST)'s gross profit in fiscal 2025?
- BIOHARVEST SCIENCES INC. (BHST) reported gross profit of $20.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $13.9 million the year before (+46.9%). Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What was BIOHARVEST SCIENCES INC. (BHST)'s operating income in fiscal 2025?
- BIOHARVEST SCIENCES INC. (BHST) reported operating income of -$5.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$7 million the year before. Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What was BIOHARVEST SCIENCES INC. (BHST)'s net income in fiscal 2025?
- BIOHARVEST SCIENCES INC. (BHST) reported net income of -$11.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$12.9 million the year before. Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What was BIOHARVEST SCIENCES INC. (BHST)'s cash from operating activities in fiscal 2025?
- BIOHARVEST SCIENCES INC. (BHST) reported cash from operating activities of -$7.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$6.7 million the year before. Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What was BIOHARVEST SCIENCES INC. (BHST)'s free cash flow in fiscal 2025?
- BIOHARVEST SCIENCES INC. (BHST) reported free cash flow of -$9.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$9.5 million the year before. Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What are BIOHARVEST SCIENCES INC. (BHST)'s total assets?
- As of Dec 31, 2025, BIOHARVEST SCIENCES INC. (BHST) reported total assets of $47.7 million, against $25 million a year earlier (+90.7%). Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What are BIOHARVEST SCIENCES INC. (BHST)'s total liabilities?
- As of Dec 31, 2025, BIOHARVEST SCIENCES INC. (BHST) reported total liabilities of $22.2 million, against $23.7 million a year earlier (-6.1%). Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
- What are BIOHARVEST SCIENCES INC. (BHST)'s cash and cash equivalents?
- As of Dec 31, 2025, BIOHARVEST SCIENCES INC. (BHST) reported cash and cash equivalents of $23 million, against $2.4 million a year earlier (+863.4%). Source: the 40-F filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BHST&period_type=annual&limit=5"Information only, not investment advice.